Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique (Q46890950)

26 December 2017

title

Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique (English)

1 reference

26 December 2017

author

David Siderovski

9

1 reference

26 December 2017

author name string

S Hossein Fatemi

1

1 reference

26 December 2017

Teri J Reutiman

2

1 reference

26 December 2017

Timothy D Folsom

3

1 reference

26 December 2017

Christopher Bell

4

1 reference

26 December 2017

Lisa Nos

5

1 reference

26 December 2017

Peter Fried

6

1 reference

26 December 2017

David A Pearce

7

1 reference

26 December 2017

Sushmita Singh

8

1 reference

26 December 2017

Francis S Willard

10

1 reference

26 December 2017

Mitsunori Fukuda

11

1 reference

26 December 2017

language of work or name

English

0 references

publication date

11 January 2006

1 reference

26 December 2017

published in

Neuropsychopharmacology

1 reference

26 December 2017

volume

31

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

1888-1899

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301002

exact match

0 references

cites work

Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Microarray analysis of differentially expressed genes in rat frontal cortex under chronic risperidone treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Early changes in gene expression in two models of Batten disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Dysregulation of the fibroblast growth factor system in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reelin glycoprotein: structure, biology and roles in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Altered levels of Reelin and its isoforms in schizophrenia and mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reelin signaling is impaired in autism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Synaptotagmin IV: biochemistry, genetics, behavior, and possible links to human psychiatric disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Insulin-like growth factors, insulin resistance and schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Increased levels of serum basic fibroblast growth factor in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Robust estimators for expression analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

CART peptides as targets for CNS drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Effect of tranquilizers and antidepressants on glycogen phosphorylase of rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Glutamate as a therapeutic target in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Association between polymorphism in intron 1 of cocaine- and amphetamine-regulated transcript gene with alcoholism, but not with bipolar disorder and schizophrenia in Korean population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

RGS2: a multifunctional regulator of G-protein signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drug treatment induces differential gene expression in the rat cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Effect of phenothiazines on the activity of glycogen phosphorylase b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drug effects on brain morphology in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Genomics and variation of ionotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Mutation screening of the Homer gene family and association analysis in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Immunocytochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Altered expression of insulins I and II and their mRNAs in the islets of Langerhans in dexamethasone-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Obesity and metabolic syndrome in circadian Clock mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Liver pyruvate kinase polymorphisms are associated with type 2 diabetes in northern European Caucasians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

A Model-Based Background Adjustment for Oligonucleotide Expression Arrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301002

1 reference

26 December 2017

1 reference

26 December 2017